Universal Health Services (UHS) Cash & Equivalents (2009 - 2026)

Universal Health Services has reported Cash & Equivalents for 18 years, with the latest figure at $119.0 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 6.09% year-over-year to $119.0 million; the trailing twelve-month figure through Mar 2026 stood at $119.0 million (down 6.09% YoY), and the FY2025 full-year result was $137.8 million, up 9.38% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $119.0 million, down from $137.8 million in the prior quarter.
• The five-year high for Cash & Equivalents was $137.8 million in Q4 2025, with the low at $74.6 million in Q3 2022.
• Historically, Cash & Equivalents has averaged $112.5 million across 5 years, with a median of $112.9 million in 2025.
• Annual changes were most pronounced in 2022 — Cash & Equivalents plunged 86.13% — and 2024, when it jumped 62.09%.
• Universal Health Services' Cash & Equivalents stood at $102.8 million in 2022, then gained by 16.17% to $119.4 million in 2023, then increased by 5.48% to $126.0 million in 2024, then gained by 9.38% to $137.8 million in 2025, then dropped by 13.62% to $119.0 million in 2026.
• The last three Cash & Equivalents figures came in at $119.0 million (Q1 2026), $137.8 million (Q4 2025), and $112.9 million (Q3 2025), per Business Quant data.